Skip to content

Cintas CTAS Investments

Investments at other companies

Principal Financial Group logo
Principal Financial GroupPFG
$110.86B+5.3%
CVS Health logo
CVS HealthCVS
$32.41B+12.1%
Cigna logo
CignaCI
$18.9B+23.1%
Monster Beverage logo
Monster BeverageMNST
$770.4M
EVERTEC logo
EVERTECEVTC
$6.1M+16.2%
Dominion Energy logo
Dominion EnergyD
$9.47B+13.1%

Other financials

Income statement

See full
Revenue$2.8B+8.9%
Gross profit$1.4B+9.8%
Operating income$659.9M+8.2%
Net income$502.5M+8.4%
EPS (diluted)$1.24+9.7%

Balance sheet

See full
Cash & equivalents$183.2M-24.7%
Total debt$2.9B-7.1%
Total equity$4.8B+4.3%
Total assets$10.2B+6.5%

Cash flow

See full
Operating cash flow$621.5M+0.2%
CapEx$90.9M-9.0%
Free cash flow$530.6M+1.9%

Valuation

See full
Market cap$68.4B-3.9%
Enterprise value$71.14B-4.0%
P/E35.3×-4.7×
P/S6.2×-0.8×

Profitability

See full
Gross margin50.4%+0.9pp
Operating margin23%+0.2pp
Net margin17.6%0.0pp
FCF margin16.3%-1.6pp

Returns & leverage

See full
Return on equity41.3%+1.0pp
Debt / equity0.6×-0.1×
Current ratio+0.3×

Where this comes from

Reported directly by Cintas in its filing.

Tagged under the XBRL concept us-gaap:Investments.

The official record: Cintas’s 10-Q, filed April 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cintas's investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cintas's investments?
Cintas (CTAS) reported investments of $407.14M in Q4 2025.
How has Cintas's investments changed year-over-year?
Cintas's investments increased by 20.9% year-over-year, from $336.89M to $407.14M.
What is the long-term trend for Cintas's investments?
Over 4 years (2021 to 2025), Cintas's investments has grown at a 5.4% compound annual growth rate (CAGR), from $274.62M to $339.52M.
What does investments mean?
This includes long-term financial investments, such as equity holdings in other companies, long-term debt securities, or other non-operating assets. These assets are held for strategic purposes or long-term capital appreciation rather than immediate operational use. It provides insight into the company's non-core financial activities and potential sources of secondary income.